Okubo S, Konno K, Ishizaki T, Suganuma T, Takubo T, Takizawa T, Tanaka M
Department of Pulmonary Disease, Tokyo Teishin Hospital, Japan.
Eur J Clin Pharmacol. 1988;34(1):55-9. doi: 10.1007/BF01061418.
To investigate the means by which doxapram affects the control of ventilation, ventilatory function and P0.1 have been related to serum doxapram concentration during a 45-min infusion of doxapram hydrochloride in 7 healthy, conscious subjects under normoxic conditions. Serum doxapram concentrations increased during the infusion: 1.88, 2.48, 3.42, and 3.97 micrograms/ml after 5, 10, 30 and 45 min, respectively. The majority of significant changes in the measurements from the baseline were observed at 30 and 45 min: VE, VT, P0.1, P0.1/end-tidal CO2 tension, VT/Ti and blood pressure were increased, and end-tidal CO2 tension was decreased. No significant changes in Pdimax, Ti/Ttot, VE/P0.1, and P0.1/(VT/Ti) were observed. A correlation was observed between the % increases in P0.1 and VE and doxapram concentration, and between VE and P0.1. The doxapram-induced increase in VE appears to be caused by increased neural drive. It is related to the serum drug concentration in the conscious subject.
为研究多沙普仑影响通气控制的机制,在常氧条件下,对7名健康清醒受试者静脉输注盐酸多沙普仑45分钟,期间监测通气功能和吸气压力(P0.1),并分析其与血清多沙普仑浓度的关系。输注过程中血清多沙普仑浓度升高:5、10、30和45分钟时分别为1.88、2.48、3.42和3.97微克/毫升。与基线相比,大多数测量指标的显著变化出现在30和45分钟时:每分通气量(VE)、潮气量(VT)、P0.1、P0.1/呼气末二氧化碳分压、VT/吸气时间(Ti)和血压升高,呼气末二氧化碳分压降低。最大吸气压(Pdimax)、Ti/总呼吸时间(Ttot)、VE/P0.1和P0.1/(VT/Ti)无显著变化。P0.1和VE的升高百分比与多沙普仑浓度之间以及VE和P0.1之间均存在相关性。多沙普仑引起的VE增加似乎是由神经驱动增加所致,且与清醒受试者的血清药物浓度有关。